High flow oxygen supplementation during shock therapy

A randomized crossover trial comparing apneic oxygenation versus conventional treatment during the seizure duration of ECT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036760

Enrollment

Registered

2021-09-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F209- Schizophrenia, unspecified

Interventions

Intervention1: conventional treatment: the patient is not oxygenated during the seizure duration Control Intervention1: apneic oxygenation: oxygen via nasal prongs at 15l/min during the seizure durati

Eligibility

Inclusion criteria

Inclusion criteria: all patients between ages of 18 and 70 years posted for ECT whose relatives consent for the trial will be included

Exclusion criteria

Exclusion criteria: less than 18 years and >70 years will be excluded

Design outcomes

Primary

Measure	Time frame
lowest recorded oxygen saturation and time for recovery of saturation from lowest recorded to 95%Timepoint: immediately after termination of seizure.	—

Secondary

Measure	Time frame
hemodynamic changes(heart rate,blood pressure) in relation to episodes of desaturation.Timepoint: immediately post termination of seizure at baseline, 10 mins and 30mins.	—

Countries

India

Contacts

Public Contactjacob chandy

CMC Vellore

yakobchandy1986@gmail.com04162282105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026